Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 90801-90850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05163951
Trabeculectomy Versus Peripheral Iridectomy Plus Goniotomy in Advanced PACG
NARecruiting
88 participants
Started: Jan 5, 2022 · Completed: Jun 30, 2026
1 condition7 sponsors1 location
NCT05151848
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
PHASE4Recruiting
100 participants
Started: Jan 5, 2022 · Completed: Jan 15, 2026
1 condition1 sponsor4 locations
NCT04929379
A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes
PHASE2Active, not recruiting
40 participants
Started: Jan 4, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors4 locations
NCT04892173
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
PHASE3Recruiting
500 participants
Started: Jan 4, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor171 locations
NCT03762733
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
N/AEnrolling by invitation
500 participants
Started: Jan 4, 2022 · Completed: Dec 29, 2028
3 conditions1 sponsor1 location
NCT05290337
ZR-CHOP in DLBCL With Specific Gene Abnormality
PHASE2Recruiting
62 participants
Started: Jan 4, 2022 · Completed: Jan 4, 2026
1 condition1 sponsor1 location
NCT04719988
Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.
PHASE2Active, not recruiting
55 participants
Started: Jan 4, 2022 · Completed: Jul 5, 2026
1 condition2 sponsors10 locations
NCT05430360
Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for the Treatment of Metastatic/recurrent Advanced Solid Tumors
PHASE1Recruiting
30 participants
Started: Jan 4, 2022 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT04651296
Compassion Meditation vs. Health Education for Veterans
PHASE2Active, not recruiting
142 participants
Started: Jan 4, 2022 · Completed: Feb 28, 2026
3 conditions1 sponsor1 location
NCT05102019
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
NARecruiting
380 participants
Started: Jan 4, 2022 · Completed: Jan 31, 2032
1 condition1 sponsor75 locations
NCT05024162
Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour
NARecruiting
60 participants
Started: Jan 4, 2022 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT05443178
Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy
PHASE1Recruiting
16 participants
Started: Jan 4, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT04529434
Star Homes Project 2
NARecruiting
2,750 participants
Started: Jan 4, 2022 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT05489042
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
NARecruiting
80 participants
Started: Jan 4, 2022 · Completed: Mar 31, 2027
3 conditions3 sponsors1 location
NCT04996628
Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis
NARecruiting
150 participants
Started: Jan 4, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors3 locations
NCT05118789
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
PHASE1/PHASE2Recruiting
359 participants
Started: Jan 4, 2022 · Completed: Oct 31, 2026
2 conditions1 sponsor63 locations
NCT05190666
Healthy Living After Knee Replacement
NARecruiting
212 participants
Started: Jan 4, 2022 · Completed: Dec 30, 2026
2 conditions2 sponsors1 location
NCT04969094
Reducing Fall Risk With NMES
NARecruiting
80 participants
Started: Jan 4, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05191706
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
PHASE4Recruiting
60 participants
Started: Jan 4, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor9 locations
NCT06786858
Hand Exoskeleton Training Study
NARecruiting
15 participants
Started: Jan 4, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT05071300
A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
PHASE3Active, not recruiting
151 participants
Started: Jan 4, 2022 · Completed: Aug 31, 2029
1 condition1 sponsor33 locations
NCT06080945
Tailored Pharmacist-led Intervention to Improve Adherence to Budesonide
NARecruiting
102 participants
Started: Jan 4, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05174871
Time-Restricted Feeding in Children and Adolescents With Obesity
NAActive, not recruiting
67 participants
Started: Jan 4, 2022 · Completed: Jun 30, 2024
2 conditions1 sponsor1 location
NCT04982653
Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
PHASE2Recruiting
140 participants
Started: Jan 4, 2022 · Completed: Apr 30, 2026
3 conditions1 sponsor1 location
NCT05194254
MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD
NARecruiting
68 participants
Started: Jan 4, 2022 · Completed: Jun 30, 2025
5 conditions1 sponsor1 location
NCT04352036
Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)
N/ARecruiting
465 participants
Started: Jan 4, 2022 · Completed: Feb 20, 2030
1 condition1 sponsor13 locations
NCT05110937
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis
N/ARecruiting
450 participants
Started: Jan 4, 2022 · Completed: Apr 30, 2027
2 conditions2 sponsors1 location
NCT05093959
Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction
PHASE2Active, not recruiting
86 participants
Started: Jan 4, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors2 locations
NCT04984629
Study of the ReGelTec HYDRAFIL System
NAActive, not recruiting
35 participants
Started: Jan 4, 2022 · Completed: Nov 6, 2025
1 condition1 sponsor1 location
NCT05041374
Evaluation of Patients With Gastrointestinal Disease
N/ARecruiting
4,000 participants
Started: Jan 4, 2022 · Completed: Dec 31, 2035
2 conditions1 sponsor1 location
NCT04943926
Dietary Strategies for Remission of Type 2 Diabetes
NARecruiting
600 participants
Started: Jan 4, 2022 · Completed: Dec 31, 2040
6 conditions5 sponsors1 location
NCT06527183
Fibromyalgia and Small Fiber Neuropathy
N/ARecruiting
150 participants
Started: Jan 4, 2022 · Completed: May 31, 2026
1 condition1 sponsor2 locations
NCT06602635
Hybrid Score to Predict OTVA-SOO in Patients with Wide Basal QRS
N/ARecruiting
100 participants
Started: Jan 4, 2022 · Completed: Oct 23, 2024
3 conditions5 sponsors6 locations
NCT05066308
Cannabidiol for Reduction of Brain Neuroinflammation
PHASE2Recruiting
80 participants
Started: Jan 4, 2022 · Completed: Dec 15, 2026
2 conditions1 sponsor1 location
NCT05363371
Minds and Mentors Program- R33
NARecruiting
240 participants
Started: Jan 4, 2022 · Completed: Aug 31, 2024
3 conditions4 sponsors4 locations
NCT06550102
Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies
N/ARecruiting
1,000 participants
Started: Jan 4, 2022 · Completed: Dec 31, 2031
1 condition1 sponsor1 location
NCT05037123
Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain
PHASE3Active, not recruiting
765 participants
Started: Jan 4, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors14 locations
NCT05117255
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
NARecruiting
256 participants
Started: Jan 4, 2022 · Completed: Mar 1, 2026
5 conditions1 sponsor1 location
NCT06541080
Collection of Liquid Biopsy Samples of Neuroendocrine Neoplasms (NEN) Patients - Collection of NET (CollectNET) 2.0, a Study by the BE-FORCE Consortium
N/ARecruiting
550 participants
Started: Jan 3, 2022 · Completed: Dec 4, 2030
1 condition4 sponsors8 locations
NCT04969081
Impact of Work Activity on SUD Outcomes
NAActive, not recruiting
103 participants
Started: Jan 3, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05326880
5-year Follow up Study on the Comparative Performance of Two-piece Zirconia and Titanium Implants
NARecruiting
60 participants
Started: Jan 3, 2022 · Completed: Mar 31, 2028
3 conditions1 sponsor2 locations
NCT05149534
rTMS-augmented Written Exposure Therapy for PTSD
NARecruiting
98 participants
Started: Jan 3, 2022 · Completed: Jan 29, 2027
1 condition2 sponsors1 location
NCT06797934
Establishment of a Registry of Patients With Parathyroid Disease
N/ARecruiting
1,200 participants
Started: Jan 3, 2022 · Completed: Dec 31, 2039
2 conditions1 sponsor1 location
NCT04939090
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
PHASE3Recruiting
360 participants
Started: Jan 3, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors290 locations
NCT04793776
Manage Emotions to Reduce Aggression (MERA)
NARecruiting
204 participants
Started: Jan 3, 2022 · Completed: Jun 30, 2026
3 conditions6 sponsors2 locations
NCT04996550
Are Carvedilol and Metoprolol Succinate Comparable Treatments in Heart Failure Patients With Reduced Ejection Fraction
N/ANot yet recruiting
5,600 participants
Started: Jan 3, 2022 · Completed: Dec 18, 2028
1 condition1 sponsor1 location
NCT05165901
Clinical Effect of LG Medipain for Managing Chronic Pain Disorders
NARecruiting
90 participants
Started: Jan 3, 2022 · Completed: Jan 15, 2025
4 conditions1 sponsor1 location
NCT05192408
Multi-component Intervention for Reducing Fear of Falling in Community-dwelling Older Adults
NAActive, not recruiting
420 participants
Started: Jan 3, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT04642352
Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough
N/ARecruiting
50 participants
Started: Jan 3, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT03438526
The Basel BOMP-AID Randomized Trial
PHASE4Recruiting
190 participants
Started: Jan 3, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location